Tartrate salts or complexes of quinazoline based EGFR inhibitors containing a zinc binding moiety

Details for Australian Patent Application No. 2008299896 (hide)

Owner Curis, Inc.

Inventors Qian, Changgeng; Zhai, Haixiao; Cai, Xiong

Agent Pizzeys

Pub. Number AU-B-2008299896

PCT Pub. Number WO2009/035718

Priority 60/971,056 10.09.07 US

Filing date 10 March 2008

Wipo publication date 19 March 2009

Acceptance publication date 2 February 2012

International Classifications

C07D 239/86 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07C 217/94 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/035718 Priority application(s): WO2009/035718

2 February 2012 Application Accepted

  Published as AU-B-2008299896

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008299903-Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors

2008299885-Pharmaceutical compositions containing clostridium difficile toxoids A and B